Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Evaluation of the Prostate
暂无分享,去创建一个
[1] Y. Yamashita,et al. The value of dynamic MR imaging for hypointensity lesions of the peripheral zone of the prostate. , 1998, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.
[2] T. Stamey,et al. Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens. , 2000, The Journal of urology.
[3] T Okada,et al. Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. , 2001, Urology.
[4] Mark Slifstein,et al. Positron emission tomography: imaging and quantification of neurotransporter availability. , 2002, Methods.
[5] I. Floriani,et al. Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. , 2008, AJR. American journal of roentgenology.
[6] G. Zaharchuk,et al. Theoretical Basis of Hemodynamic MR Imaging Techniques to Measure Cerebral Blood Volume, Cerebral Blood Flow, and Permeability , 2007, American Journal of Neuroradiology.
[7] A S Whittemore,et al. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.
[8] M. Cohn,et al. Magnetic Resonance Investigations of Ternary Complexes of Enzyme–Metal–Substrate , 1962, Nature.
[9] T Kubota,et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. , 1993, Radiology.
[10] H. Huisman,et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.
[11] J. Mohler,et al. Preoperative prediction of pathological tumor volume and stage in clinically localized prostate cancer: comparison of digital rectal examination, transrectal ultrasonography and magnetic resonance imaging. , 1991, The Journal of urology.
[12] P H Bland,et al. Carcinoma of the prostate: MR images obtained with body coils do not accurately reflect tumor volume. , 1991, AJR. American journal of roentgenology.
[13] T. Stamey,et al. Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate , 1990, Cancer.
[14] D. Cosgrove,et al. Angiogenesis imaging in the management of prostate cancer , 2005, Nature Clinical Practice Urology.
[15] D. Dearnaley,et al. Dynamic contrast-enhanced MRI for prostate cancer localization. , 2009, The British journal of radiology.
[16] H. Hricak,et al. Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations. , 2004, Radiology.
[17] P. Tofts. Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.
[18] P. Carroll,et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. , 2004, AJR. American journal of roentgenology.
[19] M Recht,et al. Method for the quantitative assessment of contrast agent uptake in dynamic contrast‐enhanced MRI , 1994, Magnetic resonance in medicine.
[20] T. Stamey,et al. Morphometric and clinical studies on 68 consecutive radical prostatectomies. , 1988, The Journal of urology.
[21] Clare Allen,et al. How good is MRI at detecting and characterising cancer within the prostate? , 2006, European urology.
[22] D. Beyersdorff,et al. Simultaneous Quantification of Perfusion and Permeability in the Prostate Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging with an Inversion-Prepared Dual-Contrast Sequence , 2009, Annals of Biomedical Engineering.
[23] G M Bydder,et al. Gadolinium‐DTPA as a Contrast Agent in MR Imaging—Theoretical Projections and Practical Observations , 1985, Journal of computer assisted tomography.
[24] L J van Erning,et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. , 1994, Radiology.
[25] K. Yamada,et al. Visualization of prostate cancer using dynamic contrast-enhanced MRI: comparison with transrectal power Doppler ultrasound. , 2003, The British journal of radiology.
[26] Peter H Gann,et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. , 2002, Journal of the National Cancer Institute.
[27] P. Scardino,et al. Is tumor volume an independent prognostic factor in clinically localized prostate cancer? , 2004, The Journal of urology.
[28] J Kurhanewicz,et al. Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. , 1998, Radiology.
[29] F. Kiessling,et al. Detektion von Prostatakarzinomen mit T1-gewichteter Kontrastmittel-unterstützter dynamischer MRT , 2003, Der Radiologe.
[30] C. Kim,et al. Localization of Prostate Cancer Using 3T MRI: Comparison of T2-Weighted and Dynamic Contrast-Enhanced Imaging , 2006, Journal of computer assisted tomography.
[31] H. Carr,et al. The Principles of Nuclear Magnetism , 1961 .
[32] W J Manning,et al. Studies of Gd‐DTPA relaxivity and proton exchange rates in tissue , 1994, Magnetic resonance in medicine.
[33] S. Kitano,et al. Diagnostic usefulness of endorectal magnetic resonance imaging with dynamic contrast‐enhancement in patients with localized prostate cancer: Mapping studies with biopsy specimens , 1999, International journal of urology : official journal of the Japanese Urological Association.
[34] D. Hoak,et al. Prostate cancer: correlation of digital rectal examination, transrectal ultrasound and prostate specific antigen levels with tumor volumes in radical prostatectomy specimens. , 1990, The Journal of urology.
[35] D P Dearnaley,et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. , 2000, Clinical radiology.
[36] R M Weisskoff,et al. Water diffusion and exchange as they influence contrast enhancement , 1997, Journal of magnetic resonance imaging : JMRI.
[37] R. Harris. Nuclear magnetic resonance spectroscopy : a physicochemical view , 1985 .
[38] B. McNeil,et al. Comparison of Magnetic Resonance Imaging and Ultrasonography in Staging Early Prostate Cancer. Results of a Multi-Institutional Cooperative Trial , 1991, Investigative Radiology.
[39] J. Barentsz,et al. Staging urinary bladder cancer: value of T1-weighted three-dimensional magnetization prepared-rapid gradient-echo and two-dimensional spin-echo sequences. , 1995, AJR. American journal of roentgenology.
[40] Gabriel P. Krestin,et al. Contrast‐Enhanced Endorectal Coil MRI in Local Staging of Prostate Carcinoma , 1995, Journal of computer assisted tomography.
[41] J. Heiken,et al. Evaluation of the prostate and prostatic carcinoma with gadolinium-enhanced endorectal coil MR imaging. , 1993, Radiology.
[42] T. Stamey,et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. , 1988, The New England journal of medicine.
[43] P. Tofts,et al. Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.
[44] M. Kattan,et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. , 2005, The Journal of urology.
[45] T. Stamey,et al. PATTERNS OF PROGRESSION IN PROSTATE CANCER , 1986, The Lancet.
[46] J E Husband,et al. The role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma. , 1996, Clinical radiology.
[47] A R Padhani,et al. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics , 1997, Journal of magnetic resonance imaging : JMRI.
[48] C S Patlak,et al. Measurements of dog blood-brain transfer constants by ventriculocisternal perfusion. , 1975, The American journal of physiology.
[49] Clare Allen,et al. MR imaging of prostate after treatment with high-intensity focused ultrasound. , 2008, Radiology.
[50] Ruth Etzioni,et al. Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends , 2008, Biometrics.
[51] M. L. Wood,et al. Proton relaxation enhancement , 1993, Journal of magnetic resonance imaging : JMRI.
[52] R. Hendrick,et al. Basic physics of MR contrast agents and maximization of image contrast , 1993, Journal of magnetic resonance imaging : JMRI.
[53] J Alfred Witjes,et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. , 2005, Radiology.
[54] Scott Fields,et al. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution , 1997, Nature Medicine.
[55] H. Kung,et al. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[56] M. Kattan,et al. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis , 2007, BJU international.
[57] J R Thornbury,et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. , 1997, Radiology.
[58] J. García-Segura,et al. Comparison of digital rectal examination, transrectal ultrasonography, and multicoil magnetic resonance imaging for preoperative evaluation of prostate cancer. , 1997, European urology.
[59] H. Ahmed,et al. Rectal fistulae after salvage high‐intensity focused ultrasound for recurrent prostate cancer after combined brachytherapy and external beam radiotherapy , 2009, BJU international.
[60] A. Villers,et al. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. , 2006, The Journal of urology.
[61] N Fujita,et al. Neuromas and meningiomas: evaluation of early enhancement with dynamic MR imaging. , 1992, AJNR. American journal of neuroradiology.
[62] Clare Allen,et al. Dynamic contrast enhanced MRI in prostate cancer. , 2007, European journal of radiology.
[63] W. Kaiser,et al. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. , 1989, Radiology.
[64] B R Rosen,et al. Dynamic Gd‐DTPA enhanced MRI measurement of tissue cell volume fraction , 1995, Magnetic resonance in medicine.
[65] B. K. Park,et al. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. , 2008, AJR. American journal of roentgenology.
[66] O. Hélénon,et al. Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings. , 2000, AJR. American journal of roentgenology.
[67] Silvia D. Chang,et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. , 2002, Radiology.
[68] O Henriksen,et al. Quantitation of blood‐brain barrier defect by magnetic resonance imaging and gadolinium‐DTPA in patients with multiple sclerosis and brain tumors , 1990, Magnetic resonance in medicine.
[69] E J Halpern,et al. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. , 2000, AJR. American journal of roentgenology.
[70] Mark Rijpkema,et al. Combined quantitative dynamic contrast‐enhanced MR imaging and 1H MR spectroscopic imaging of human prostate cancer , 2004, Journal of magnetic resonance imaging : JMRI.
[71] Hendrick Re,et al. Basic physics of MR contrast agents and maximization of image contrast , 1993, Journal of magnetic resonance imaging : JMRI.
[72] R Alagappan,et al. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. , 1997, Radiology.
[73] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[74] Henkjan J Huisman,et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. , 2003, Radiology.
[75] W. Johnson,et al. Incidental prostatic carcinoma: tumor extent versus histologic grade. , 1982, Urology.
[76] L R Schad,et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. , 1991, Journal of computer assisted tomography.
[77] W T Yuh,et al. An exciting and challenging role for the advanced contrast MR imaging , 1999, Journal of magnetic resonance imaging : JMRI.
[78] S B Reeder,et al. Effects of water exchange on the measurement of myocardial perfusion using paramagnetic contrast agents , 1999, Magnetic resonance in medicine.
[79] J Kurhanewicz,et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. , 1999, Radiology.
[80] H. Hricak,et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. , 2007, International journal of radiation oncology, biology, physics.
[81] T. Miyati,et al. [Evaluation of imaging parameters for T1 dynamic contrast enhanced MRI with fast spin-echo]. , 2007, Nihon Hoshasen Gijutsu Gakkai zasshi.
[82] Robert W Veltri,et al. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. , 2003, The Journal of urology.
[83] A Heerschap,et al. Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors , 2001, Journal of magnetic resonance imaging : JMRI.
[84] G P Liney,et al. Differentiation of prostatic carcinoma and benign prostatic hyperplasia: Correlation between dynamic Gd‐DTPA‐enhanced MR imaging and histopathology , 1999, Journal of magnetic resonance imaging : JMRI.
[85] V G Kiselev. On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI , 2001, Magnetic resonance in medicine.
[86] A. Renshaw,et al. Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice. , 1997, American journal of clinical pathology.
[87] H. Huisman,et al. Accurate estimation of pharmacokinetic contrast‐enhanced dynamic MRI parameters of the prostate , 2001, Journal of magnetic resonance imaging : JMRI.
[88] B K Rutt,et al. Temporal sampling requirements for the tracer kinetics modeling of breast disease. , 1998, Magnetic resonance imaging.
[89] Robert E Lenkinski,et al. Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results. , 2007, Radiology.
[90] Jun Nakashima,et al. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. , 2004, Urology.
[91] H-U Kauczor,et al. [Detection of prostate carcinomas with T1-weighted dynamic contrast-enhanced MRI. Value of two-compartment model]. , 2003, Der Radiologe.
[92] P. Walsh,et al. Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade. , 1981, The Journal of urology.
[93] Harry J de Koning,et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. , 2003, Journal of the National Cancer Institute.